The Future of 3D Printing in Pharma, Medical Devices

life_sciences_articleThe concept seems like magic—a few strokes of a printer and a ­prescription medication or a ­customized medical device is available at your fingertips. Yet thanks to additive manufacturing, more commonly known as “3D printing,” what seems almost unimaginable is indeed reality. The popularity and utility of additive manufacturing is rapidly increasing across ­countless industries. According to one report, the 3D printing industry grew to $5.165 billion in 2015, representing a 25.9 percent growth from 2014, (TJ McCue, Wohlers Report 2016: 3D Printing Industry Surpassed $5.1 Billion, FORBES, Apr. 25, 2016). The pharmaceutical and medical device industries are no exception, and are harnessing the power of 3D printing to make innovative medical advances and bring significant patient benefits. Nevertheless, the proliferation of 3D printing comes with a host of legal implications and uncertainties. As the use of 3D printing continues to expand and evolve in the pharmaceutical and medical device space, the ­existing FDA regulatory regime and ­traditional product liability principles will be challenged to adapt.

By Raymond Williams 
and Kristina Neff | The Legal Intelligencer

READ MORE

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s